全新SKINVIVE® 昇光針® 矚目登場 — 引領突破水光界限

邂逅肌膚原生美肌隨時奢享昇光自由

香港 2025年6月24日 /美通社/ -- 全球醫學美容領導廠商 Allergan Aesthetics 引領突破水光界限，隆重宣佈全新品牌SKINVIVE^® 昇光針^®強勢登陸。與此同時，我們也非常高興宣佈著名演員蔡思韵（Cecilia）成為SKINVIVE^® 昇光針^®的品牌代言人，攜手揭秘巔峰醫美話題新作，呈現給您看得見的彈、滑、亮^1-2，賦活全方位的肌底「源」動力，膚質進階、昇光無瑕！

全球醫學美容領導品牌Allergan Aesthetics宣布著名演員蔡思韵（Cecilia）成為 SKINVIVE® 昇光針® 的最新品牌代言人。

與她一起煥啟肌源年輕深透昇光肌

作為影視界的實力派演員，Cecilia 蔡思韵以獨特的氣質和細膩專業的表演方式，吸引了無數觀眾。清新脫俗的氣質和她的優雅與誠摯恰好詮釋了SKINVIVE^® 昇光針^®強調肌膚原生之美的理念。

對她而言，皮膚水份不足會引起一連串的肌膚問題，因此護膚保濕是日常不可或缺。難怪鏡頭下的Cecilia每一幀都是高光透亮的狀態，整天光彩照人！ Cecilia亦深明護膚保養是全方位的，日常的飲食、健康生活固然重要，配合有效的醫美膚質管理皆不能少。這亦是 Cecilia 答應擔任SKINVIVE^® 昇光針^®代言人的原因，而其品牌的3 大亮點 — 高效可靠、節省時間、一次到位更是值得信賴！

蔡思韵（Cecilia）以其清新脫俗的氣質，完美演繹 SKINVIVE® 昇光針® 的原生美肌理念，其高效、省時、一次到位的三大亮點，絕對值得信賴！

唯一獲得雙重國際認證︳煥發６大新生「肌」準

SKINVIVE^®昇光針^®為第一及唯一獲得美國FDA及歐盟CE雙重認證^3-4的透明質酸水光品牌，於法國製造，使用全球No.1品牌⁵Juvéderm^®喬雅登^®的國際專利技術⁶，確保與肌膚組織融合度佳⁶，效果更自然持久⁶。

一般護膚品的透明質酸，大多只能針對皮膚表層保濕⁷，而SKINVIVE^®昇光針^®專爲還原健康膚質健康而設，其透明質酸質感較輕薄⁷，能夠輕鬆滲入肌底^8-9深透肌膚真皮層¹⁰*，從根源補濕¹⁰，並撫平細紋¹¹，煥發６大新生「肌」準^1,10 —— 水潤^†、清透^‡、提亮^§、順滑^‖、均勻色澤^¶、細緻毛孔^**，重拾健康水潤光澤感，與您一同踏上原生昇光之旅。

SKINVIVE® 昇光針® 是首個且唯一獲得美國FDA及歐盟CE雙重國際認證的透明質酸水光品牌，法國製造並採用 Juvéderm® 喬雅登® 專利技術，確保自然持久，煥發六大新生「肌」準。

唯一透明質酸水光療程帶來最長效果︳輕鬆擺脫繁複護膚步驟

締造健康透亮的肌膚，必須從源頭開始，由内而外煥活肌膚。SKINVIVE^®昇光針^®能夠提升細胞水通道（AQP３）¹²，釋放長效^深層*水潤^†之餘，讓水分從水通道帶到表層¹²，有助恢復肌膚屏障功能及彈性活力¹³。科研實證一次持效長達9個月^{10,14^}，超過96% 用家表示療程後見證肌膚更顯細滑^††，對膚質及光澤感提升了3倍滿意度^††，更滿意自己膚質¹。只需大約10-15分鐘¹⁵，即可重拾健康肌膚，打好護膚基礎。

全新SKINVIVE^®昇光針^®重塑水光巔峰，讓肌膚由內而外煥亮發光。有關療程詳細內容及價格，請向各大原廠供應的醫療中心查詢。

關於Allergan Aesthetics*

作為全球醫學美容領導廠商，Allergan Aesthetics致力於提供全面並基於科研的產品選擇，以滿足用家的不同需要。我們相信自信的力量，並一直將消費者放在首位，憑藉多年在美學領域的深耕與創新探索，讓他們做出理性的美學選擇，開啟更加自信的人生。我們恪守對卓越的承諾，為客戶提供優質的創新產品、培訓教育和專業服務，向客戶傳遞信心。

傳媒查詢：
Allergan Aesthetics	Ms Mabel Chan	[email protected]	2610 5823
MAXLYTICS Limited	Ms Fiona Cheung	[email protected]	3709 2787

^Based on a search of published clinical studies of injectable HA treatments in March 2023. A duration of 9 months of skin hydration was established with SKINVIVE™.¹¹

* Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).¹⁰

†Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively) and top-up treatment administered at Day 30 (n=31).¹⁰

§Lasting up to 9 months as reported by 63% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how radiant their facial skin looked.¹

‖ Lasting up to 9 months as reported by 55.1% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how smooth their facial skin looked.¹

**Lasting up to 9 months as reported by 55.9% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how their pores looked.¹

¶ Lasting up to 9 months as reported by 67.7% of patients. As reported by patients (127/131; 3 subjects did not respond) in a composite satisfaction score, which includes satisfaction with their skin's tone (colour).¹

‡Lasting up to 9 months as reported by 64.6% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how clear their facial skin looked.¹

††Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject's perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item.¹

References:
1. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065–1070

2. Clin Cosmet Investig Dermatol. 2022 Mar 10;15:411–426

3. SKINVIVE® by Juvéderm® is FDA approved. U.S. Food and Drug Administration, Department of Health & Human Services. SKINVIVE by Juvéderm approval letter P110033/S059, May 2023.

4. SKINVIVE® by Juvéderm® is CE approved. European Commission, hyaluronic acid based medical devices. EC certificate number: 3824296CE05

5. Allergan Aesthetics. Data on File. REF-108642. JUVÉDERM®, the world's leading brand of hyaluronic acid facial fillers claim. Mar 2023.

6. Allergan Unpublished Data. INT-VOT-2050006. Juvederm VOLITE laboratory testing: hydration and elasticity, mouldability, tissue integration, spreadability. May 2020.

7. Purnamawati S et al. Clin Med Res. 2017;15(3-4);75–87

8. Akinbiyi T et al. Plast Reconstr Surg Glob Open. 2020;8(10):e2763.

9. Lipko-Godlewska S et al. Clin Cosmet Investig Dermatol. 2021;14:169–178.

10. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.

11. SKINVIVE® by Juvéderm® DFU. 20074348. Revision 2022.09.30.

12. Safa M et al. Clin Cosmet Investig Dermatol. 2022;15:411–426.

13. Draelos Z. J Clin Aesthet Dermatol. 2012;5(7):53–56.

14. Allergan Aesthetics. Unpublished data. SKINVIVE™ by JUVÉDERM® – 9-month duration of skin hydration in clinical trials. March 2023.

15. Allergan Aesthetics. Unpublished data. SKINVIVE™ time of injection. REF-116636. October 2023.

SKINVIVE® by Juvéderm® (Hyaluronic Acid Gel with Lidocaine). All adverse events should be reported to [email protected].

Related Posts